logo
Sign InSign Up

VIATRIS INC (VTRS)

Sector: Healthcare

Financial Fundamentals

findl.com provides a comprehensive suite of standardized financial statement data and an assortment of calculated metrics sourced directly from SEC filings, and meticulously cleansed and verified, ensuring reliability. To get the complete financial statement history in quarterly and annual resolution for VTRS, sign up here.

Income Statement

Revenue

$15.4bn

Gross Profit

$6.4bn

Earning before Tax

$202.9m

Net Income

$54.7m

Net Income Common Shareholders

$54.7m

EPS

0.05

Balance Sheet

Cash

$991.9m

Debt

$18.1bn

Assets

$47.7bn

Liabilities

$27.2bn

Equity

$20.5bn

Enterprise Value

$30.1bn

Cash Flow Statement

Net Cash from Operations

$2.8bn

Net Cash from Investing

$-0.8bn

Net Cash from Financing

$-2.3bn

Net Cash Flow

$-0.3bn

Free Cash Flow

$2.4bn

Free Cash Flow per Share

$2.03

Metrics

Price to Equity

0.0m

Price to Equity (Damodaran)

216.60

Price to Book

0.64

Net Margin

0.00

Return on Equity

0.00

Return on Sales

0.05

Get immediate access to 5-years of reference grade data for VTRS for free.

Sign up

Company Profile

Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, including noncommunicable and infectious diseases; biosimilars in the areas of oncology, immunology, endocrinology, ophthalmology, and dermatology; and APIs for antibacterial, central nervous system agents, antihistamines/antiasthmatics, cardiovascular, antivirals, antidiabetics, antifungals, and proton pump inhibitor areas, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. It provides its medicines in the form of oral solid doses, injectables, complex dosage forms, and APIs to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. The company distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies. It sells its products under the Lyrica, Lipitor, Creon, Influvac, Wixela Inhub, EpiPen auto-injector, Fraxiparine, and Yupelri; Norvasc and Viagra; AMITIZA, Lipacreon, and Effexor; and Celebrex and ARV names, as well as glargine and SEMGLEE names. The company has collaboration and licensing agreements with Revance Therapeutics, Inc.; Momenta Pharmaceuticals, Inc.; Theravance Biopharma, Inc.; and Fujifilm Kyowa Kirin Biologics Co. Ltd. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania.

Company Info

Industry

Drug Manufacturers - Specialty & Generic

Employees

38,000

Address

1000 Mylan Boulevard
Canonsburg, PA 15317
United States

Phone

724 514 1800

Last Updated

2024-02-15

Available Data

Standardized Financial Statements

EOD Price History

Corporate Actions

Institutional Holdings

Insider Transactions

Sign up for free and get immediate access
logo

Radically accessible financial data

Contact Info

findl.com info@findl.com

Explore findl data

DocumentationSupport

Copyright © findl 2024. All rights reserved.

Terms & Use

Privacy Policy